POSACONAZOL Accord susp 40 mg/ml buvable 105 ml
7680673660010
CH-67366
J02AC04
08.06.0.
Reimbursement limitations:
NOXAFIL2
La prophylaxie chez des patients à risque élevé (voir 1a et 1b) peut être prescrit …
1 / 3
google
Details
- Product number
- 6736601
- CPT
- -
- Packaging group
- 105
- Unit
- ml
- Composition
- posaconazolum 200 mg, macrogolglyceroli hydroxystearas 25 mg, natrii citras dihydricus, acidum citricum monohydricum, dimeticonum, silica colloidalis hydrica, methylcellulosum, acidum sorbicum, polysorbatum 65, macrogoli stearas, xanthani gummi, glucosum liquidum 1.75 g, glycerolum, acidum benzoicum < 12 µg, acidum sulfuricum, aromatica (Erdbeeraroma), propylenglycolum 10.86 mg, E 171, E 211 11.4 mg, aqua purificata, ad suspensionem pro 5 ml corresp., natrium 2.52 mg.
Articles (1)
Posaconazol Accord 40 mg/ml, Suspension zum Einnehmen
suspension
105
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
25.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
1.75 G | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | AROMA |
|
(N/A)
|
10.86 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
11.4 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
2.52 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 574.50
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/12/2020
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 67366
- Drug name
- Posaconazol Accord, Suspension zum Einnehmen
- Galenic form
- SUOR
- ATC Code
- J02AC04
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 30/01/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 08.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- POSACONAZOL Accord susp 40 mg/ml buvable 105 ml
- Description (DE)
- POSACONAZOL Accord Susp 40 mg/ml zum Einneh 105 ml
- Market launch
- 30/01/2020
- Narcotic (BTM)
- No